BioSpace News Archive

Aedes aegypti mosquitoes transmit dengue, Zika and other diseases in people and heartworm and other deadly diseases to pets and animals

University of Alabama at Birmingham’s biotech startup Resbiotic, Inc. announced a $3M seed round to support the development and commercialization of groundbreaking probiotic formulations for lung health.

Recro Pharma, Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced that the company will release financial results for the first quarter 2021 after the market close on Thursday, May 6, 2021.

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, announced that it will report first quarter 2021 financial results after the U.S. financial markets close on Thursday, May 6, 2021.

Spero Therapeutics, Inc. announced that it will host a conference call and live audio webcast on May 6, 2021 at 4:30 p.m. ET to report its first quarter 2021 financial results and provide an update on its business and pipeline.

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that it will report its first quarter financial results along with recent company highlights after the close of the U.S. financial markets on Thursday, May 6, 2021.

Y-mAbs Therapeutics, Inc. announced that it will report its financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021, after the close of the U.S. financial markets.

TELA Bio, Inc., a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced that the company will report first quarter ended March 31, 2021, financial results on Thursday, May 13, 2021.

Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced that its management team will present at the 2021 Bank of America Healthcare Conference on Thursday, May 13, 2021 at 8:45 a.m. Eastern Time.

Small business, Evon Medics, LLC today announced that it has been awarded a non-dilutive grant of $2.5 million for its SBIR (Small Business Innovation Research) Phase II clinical trials for the development and evaluation of its non-invasive Computerized Olfactory Training (COT) medical device for home-based treatment of Alzheimer’s